Primary hyperoxaluria in Italy: the past 30 years and the near future of a (not so) rare disease
Open Access
- 26 February 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 35 (3) , 841-850
Abstract
Background: Primary hyperoxalurias (PHs) are rare autosomal recessive diseases of the glyoxylate metabolism; PH1 is caused by mutations in the AGXT gene, PH2 in GRHPR and PH3 in HOGA1 . Methods: Here we report the first large multi-center cohort of Italian PH patients collected over 30 years (1992–2020 median follow-up time 8.5 years). Complete genotype was available for 94/95 PH1 patients and for all PH2 (n = 3) and PH3 (n = 5) patients. Symptoms at onset were mainly nephrolithiasis (46.3%) and nephrocalcinosis (33.7%). Median age at onset of symptoms and diagnosis were 4.0 years and 9.9 years, respectively. Results: Fifty-four patients (56.8%) were diagnosed after chronic kidney disease. Sixty-three patients (66.3%) developed end stage kidney disease (median age 14.0 years). Twenty-one patients had a kidney-only transplant and, among them, seven had a second kidney transplant combined with liver transplant. A combined kidney–liver transplant was carried out in 29 patients and a sequential kidney–liver transplant was performed in two. In five cases a preemptive liver transplant was performed. Those receiving a liver-only transplant tended to have lower kidney function at last follow-up. Conclusion: Our study of PHs in Italy underlines a considerable diagnostic delay, which has only slightly decreased in recent years. Therefore, we suggest a more extensive use of both metabolic screening among patients with recurrent kidney stones and genotyping, including unambiguous assignment of minor/major allele status in order to promptly begin appropriate treatment. This will be fundamental in order to have access to the new therapies, which are mainly focused on substrate reduction for the oxalate-producing enzymes using RNA-interference. GraphicalKeywords
This publication has 32 references indexed in Scilit:
- Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type IMolecular Genetics and Metabolism, 2012
- Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variantBiochimie, 2010
- Mutations in DHDPSL Are Responsible For Primary Hyperoxaluria Type IIIThe American Journal of Human Genetics, 2010
- Mutation-based diagnostic testing for primary hyperoxaluria type 1: Survey of resultsClinical Biochemistry, 2008
- Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implicationsBiochemical Journal, 2007
- Comprehensive Mutation Screening in 55 Probands with Type 1 Primary Hyperoxaluria Shows Feasibility of a Gene-Based DiagnosisJournal of the American Society of Nephrology, 2007
- The major allele of the alanine:glyoxylate aminotransferase gene: Nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1Molecular Genetics and Metabolism, 2005
- Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxaluriasKidney International, 2004
- Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2Human Mutation, 2003
- Primary hyperoxaluria type 1: Genotypic and phenotypic heterogeneityJournal of Inherited Metabolic Disease, 1994